Xylem Inc.·4

Mar 7, 4:14 PM ET

McShane Geri-Michelle 4

4 · Xylem Inc. · Filed Mar 7, 2025

Insider Transaction Report

Form 4
Period: 2025-03-07
Transactions
  • Sale

    Common Stock

    2025-03-07$128.18/sh4,119$527,9783,950 total
  • Exercise/Conversion

    Common Stock

    2025-03-07$80.66/sh+3,119$251,5798,069 total
  • Exercise/Conversion

    Non-Qualified Stock Options (Right to Buy)

    2025-03-073,1190 total
    Exercise: $80.66Exp: 2030-02-27Common Stock (3,119 underlying)
Footnotes (2)
  • [F1]This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 4,119 Shares were executed at a range of prices from $127.50 to $128.38. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
  • [F2]The February 27, 2020 option grant vested 1,030 options on February 27, 2021, 1,029 options on February 27, 2022, and 1,060 options on February 27, 2023.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT